Q1-FY24 · Jayashree Satagopan
When you look at it on an annualized basis, I think we will be in the range of INR 5,500-INR 6,000, as we had indicated earlier.
Coromandel International · tone and specificity signals across the available quarters.
Language signals
When you look at it on an annualized basis, I think we will be in the range of INR 5,500-INR 6,000, as we had indicated earlier.
Close to 50% of current use of DAP can be replaced with Nano DAP.
The eventual destination is what you just described, but, you'll appreciate, I mean, the customers would like us to graduate step by step.
The company has improved its non-subsidy EBITDA mix during the quarter, which stands at 25%, versus 16% in the previous year.
We have got approval during this quarter to expand our capacity at Kakinada by another million ton.
Our effort would be to substitute this DAP import through Nano. And we have a few, at least 2 million tons, to get replaced in at least 2-3 years time frame.
Our normative EBITDA of metric ton of 5,000 will sustain during this year. That's our hope and we'll strive to do that.
If appetite for DAP for the forthcoming Rabi seasons are met, DAP prices should soften from thereon.
This year is going to be extremely good for crop protection. The momentum what we are seeing this year will continue in the years to come.
Given the backward integration that we have, we expect the margins to be positive.
We have started in a very small way during the last quarter, token invoicing and shipments are happening to some of the specialty chemicals customers already.
The government has been considering and getting supplementary credits for disbursement of subsidy. So we hope they will be able to get it through.
Had the commodity prices have been stable, our numbers would have been much more healthier than what we are reporting now.
Our aim would be to go more on the non-subsidy piece in the coming quarter.
The prices have bottomed out is the general sentiment globally. And the expectation is that they will start going up some time middle of next year.
We have become the largest market for phosphatic fertilizers in the country. Our consumption-based market share in phosphatic fertilizers stands at 19% vs 17% last year.
The value addition of Sulfuric acid will bring in the desired savings. When I say that a INR 1,000 crore investment will pay back in two, two and a half years' time, you can understand the economic in terms of what it can add to the bottomline.
We are looking at various synergy areas by aligning our policies, R&D, product development, manufacturing infrastructure, and market access. Overall, on a combined basis, crop protection business is likely to do well.
The government has issued an office memorandum in January, which gives the broad guidelines in terms of the reasonableness margin for all the fertilizer companies.
Our nano plant in Kakinada has to come full stream, and we also want to wait and see how these new technology adoptions are happening.
Happy to state that some commercial transactions have happened during the quarter. So that beginning has happened.
Our aim would be to scale up the volume in the coming years, and we are a pan-India player for the entire nutrition segment, ranging from SSP to specialty fertilizers.
I strongly believe water-soluble fertilizers, high-end specialties, organic and bio will be the next phase of growth, and we are currently positioning ourselves for that.
So when there is so much of competition on generic actives, the only way to make money would be to enhance our presence in the formulations market, both in India and abroad.
Despite all these headwinds, the business delivered a resilient performance supported by very competitive sourcing of key raw materials, operational efficiencies, and our plants have been operating at 100% capacity utilization.
We do feel that the sulfur price increase is not sustainable. Sulfur has always used to be a disposal issue. I think it is a phenomenon of short supply and excess demand, which should get moderated as we move into the first quarter of next year.
Our game plan will be to expand our market territories and synergize our operations with NACL also. We'll be looking to increase our formulation business and domestic market by at least 20%-25% going year-on-year from now on.
The margins for next year, we are expecting in the range of about INR 4,500-5,000 per ton in terms of EBITDA.
Our aim in terms of improving the EBITDA margins are not by increasing prices, but by improving our operational efficiencies, bringing the value-added products.
Dhaksha's order book stands at around INR 250 crore, and the company plans to service the same in the first half of the year.
Our aim would be to continue what they've been doing well and try and see how do we restore the margins what they've been making two years before.
Nano DAP is going to be a game changer for the industry as a whole. If everything happens in the way we expect, we do expect replacement of 2 million tons of DAP in another two to three years' time.
We should be able to sustain that margin.
We have been diversifying our raw material sources through long-term contracts with various countries beyond Saudi and Qatar, like Southeast Asian countries, African countries, and Canada, and sometimes from Russia and China as well.
These are very extraordinary times, very difficult to look at margin at this point of time. It doesn't make sense even to look at whether product margin or the phosphate value gap.
We strongly believe during this period of challenge and crisis, alternate solutions like nanotechnology can make a huge impact and can save the country from the huge foreign exchange outflow as well as help the farmers to have the right nutrient application for the crop.